Updates On Immunotherapy For Colorectal Ncbi Nih

No view
  • Despite significant advances in standard of care therapies, the year survival rate for metastatic colorectal CRC remains around ..

  • Core tip The prognosis for patients with recurrent or metastatic colorectal CRC is extremely poor. Immunotherapy may be effective for treating CRC .

  • J Gastrointest Oncol. Feb . doi . jgo Updates on immunotherapy for colorectal. Kalyan A , Kircher S , Shah .

  • Key immunotherapy trials in metastatic colorectal CRC . Recent updated results have remained encouraging, with of .

Updates on immunotherapy for colorectal ncbi nih